
GV
4.7K posts

GV
@GVteam
Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward.



AI is code, and now that AI can code, we can close the self-improvement loop. GV is proud to co-lead the early round for @recursive_si as they build systems that safely automate the scientific method to achieve superintelligence. Congrats @richardsocher & team!





𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: @GVteam's @kyeshwant describes his well-rounded background in both software and medicine, and the evolution of GV since its start. Full video: biotechtv.com/post/bioventur…

We raised $6M to bring the future of filmmaking into your hands. Today, the premiere of our first Flick Residency Film Series is now live. 14 filmmakers. 13 films. All made on Flick. Founded by filmmaker @ZoeyZ1004 and Instagram Stories founding engineer @RuiCromwell . Backed by @trueventures , @GVteam , @ycombinator (@garrytan , @golda ), @lightspeedvp, @pioneer_fund, Formosa Capital, @OliveTreeCap , and N1.









Today marks a pivotal moment for Isomorphic Labs. We have secured $2.1 Billion in our second external funding round, led by Thrive Capital. They are joined at the table by Alphabet, GV and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund. This milestone accelerates our ability to build the pioneering novel AI models that power our AI drug design engine (IsoDDE) and deploy them at scale: delivering scientific breakthroughs with a precision previously thought impossible, accelerating and expanding our pipeline of therapeutic programs toward the clinic. All with the ultimate goal of delivering life-changing new medicines to patients. Moving forward, we will scale our drug candidate pipelines across multiple therapeutic areas, expand our global footprint, and push the boundaries of frontier AI research to power our drug design engine. Deeply grateful to everyone sharing our vision to solve all disease with AI. Let’s build the future of medicine. Read the full announcement here: bit.ly/4v2OI03



